CARISMA Therapeutics to Participate in Upcoming Investor Conferences

August 3, 2020

PHILADELPHIAJuly 30, 2020 /PRNewswire/ — CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020. Click here for more information.